Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCP) Asset Writedowns and Impairment (2016 - 2025)

Chs' Asset Writedowns and Impairment history spans 11 years, with the latest figure at $4.2 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 234.81% year-over-year to $4.2 million; the TTM value through Nov 2025 reached $13.4 million, up 640.99%, while the annual FY2025 figure was $6.1 million, 8.97% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $4.2 million at Chs, up from $101000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $10.1 million in Q1 2022 and bottomed at -$18.5 million in Q1 2023.
  • The 5-year median for Asset Writedowns and Impairment is $2.2 million (2021), against an average of $1.3 million.
  • The largest annual shift saw Asset Writedowns and Impairment tumbled 5875.93% in 2021 before it surged 261.75% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $1.5 million in 2021, then surged by 101.15% to $3.0 million in 2022, then skyrocketed by 69.17% to $5.0 million in 2023, then tumbled by 161.95% to -$3.1 million in 2024, then skyrocketed by 234.81% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for CHSCP's Asset Writedowns and Impairment are $4.2 million (Q4 2025), $101000.0 (Q3 2025), and $9.5 million (Q2 2025).